This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Metamorefix. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Mazal Dahan
Introduction
Mazal Dahan is a notable inventor based in Mazkeret Batia, Israel. She has made significant strides in the field of pharmaceuticals, particularly in the treatment of connective tissue. Her innovative work has led to the development of a unique pharmaceutical composition that has potential applications in medical treatments.
Latest Patents
Mazal Dahan holds 1 patent for her invention titled "Peptides and pharmaceutical compositions for treating connective tissue." This patent describes a pharmaceutical composition designed for sequestering cells in connective tissue. The composition features a biocompatible scaffolding to which one or more peptides or proteins are linked. These peptides or proteins possess an amino acid sequence that is a subsequence of human ficolin and are capable of binding the cells to be sequestered. This pharmaceutical composition can be utilized in the treatment of connective tissue and can also serve as a dermal filler.
Career Highlights
Mazal Dahan is currently associated with Metamorefix, a company focused on innovative solutions in the pharmaceutical sector. Her work at Metamorefix has allowed her to explore and develop groundbreaking treatments that address significant medical needs.
Collaborations
Mazal collaborates with Raphael Gorodetsky, who is also a key figure in her professional journey. Their partnership exemplifies the collaborative spirit that drives innovation in the field of pharmaceuticals.
Conclusion
Mazal Dahan's contributions to the field of pharmaceuticals, particularly through her patent for treating connective tissue, highlight her role as an innovative inventor. Her work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile